Intra-Cellular Therap
ITCI131.8700.00% ( 0.000 )
Q4 FY2024 Earnings
Financial report interval: 2024.10.01 - 2024.12.31
Overview: Intra-Cellular Therap(ITCI) the Revenue is 199.22 M (+50.81%);the EBIT is -29.2 M (+14.37%);the EPS is -0.159 (+46.38%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.20B50.81%
----
----
EBIT
-0.03B14.37%
----
----
EPS
-0.159146.38%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf